scholarly article | Q13442814 |
P356 | DOI | 10.3109/14397595.2014.987366 |
P698 | PubMed publication ID | 25528860 |
P50 | author | Fereydoun Davatchi | Q51302253 |
Farhad Shahram | Q60976342 | ||
P2093 | author name string | Farhad Gharibdoost | |
Ahmad Reza Jamshidi | |||
Pedram Paragomi | |||
Abdolhadi Nadji | |||
Azam Sadat Hoseinian | |||
Fatemeh Esfahanian | |||
Maassoumeh Akhlaghi | |||
Mahmood Akbarian | |||
Mohammad Nejadhosseinian | |||
Seyedeh Tahereh Faezi | |||
P2860 | cites work | The 1982 revised criteria for the classification of systemic lupus erythematosus | Q29547225 |
Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus | Q29614922 | ||
Avascular necrosis in SLE. An apparent predilection for young patients | Q30445300 | ||
Differences in clinical manifestations between childhood-onset lupus and adult-onset lupus: a meta-analysis | Q33397369 | ||
Avascular necrosis of bone in systemic lupus erythematosus: possible role of haemostatic abnormalities | Q33561944 | ||
Pathogenesis and natural history of osteonecrosis | Q34995796 | ||
Osteonecrosis in patients with SLE. | Q35148600 | ||
Osteonecrosis of the femoral head of laboratory animals: the lessons learned from a comparative study of osteonecrosis in man and experimental animals | Q35161681 | ||
Risk factors for avascular necrosis of bone in patients with systemic lupus erythematosus: is there a role for antiphospholipid antibodies? | Q35549358 | ||
Systemic lupus erythematosus in a multiethnic US cohort (LUMINA): XXIV. Cytotoxic treatment is an additional risk factor for the development of symptomatic osteonecrosis in lupus patients: results of a nested matched case-control study | Q35637240 | ||
Glucocorticoids in osteonecrosis of the femoral head: a new understanding of the mechanisms of action. | Q37476212 | ||
Orthopedic surgery and its complication in systemic lupus erythematosus | Q37640125 | ||
Corticosteroid therapy associated with ischemic necrosis of bone in systemic lupus erythematosus | Q42229554 | ||
Avascular necrosis prevention with lipitor in lupus erythematosus | Q46815729 | ||
Remnants of secondarily necrotic cells fuel inflammation in systemic lupus erythematosus | Q47697187 | ||
Incidence of osteonecrosis associated with corticosteroid therapy among different underlying diseases: prospective MRI study. | Q51422493 | ||
Systemic lupus erythematosus in Iran: a study of 2280 patients over 33 years. | Q51521152 | ||
Multiple avascular necrosis in a patient with systemic lupus erythematosus/systemic sclerosis overlap syndrome. | Q51551268 | ||
Aseptic necrosis of bone in systemic lupus erythematosus. | Q53767143 | ||
P433 | issue | 4 | |
P304 | page(s) | 590-594 | |
P577 | publication date | 2014-12-22 | |
P1433 | published in | Modern Rheumatology | Q15752709 |
P1476 | title | Non-corticosteroid risk factors of symptomatic avascular necrosis of bone in systemic lupus erythematosus: A retrospective case-control study | |
P478 | volume | 25 |
Q92440239 | Avascular necrosis less frequently found in systemic lupus erythematosus patients with the use of alternate day corticosteroid |
Q46516621 | High prevalence of osteonecrosis among the hemophagocytic lymphohistiocytosis population: Single institution 10-year retrospective data review. |
Q51757617 | Temporal course of avascular femoral head necrosis in patients with pemphigus vulgaris. |
Search more.